| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | navitoclax:pluripotin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.053 | 0.2 |
| mRNA | BRD-K88742110 | CTRPv2 | pan-cancer | AAC | 0.053 | 0.2 |
| mRNA | thapsigargin | gCSI | pan-cancer | AAC | 0.089 | 0.2 |
| mRNA | WZ3105 | GDSC1000 | pan-cancer | AAC | -0.045 | 0.2 |
| mRNA | GSK2126458 | GDSC1000 | pan-cancer | AAC | -0.048 | 0.2 |
| mRNA | Dasatinib | CTRPv2 | pan-cancer | AAC | 0.052 | 0.2 |
| mRNA | narciclasine | CTRPv2 | pan-cancer | AAC | 0.047 | 0.2 |
| mRNA | XMD15-27 | GDSC1000 | pan-cancer | AAC | -0.051 | 0.2 |
| mRNA | SU11274 | CTRPv2 | pan-cancer | AAC | -0.05 | 0.2 |
| mRNA | Irinotecan | CCLE | pan-cancer | AAC | -0.078 | 0.2 |